UBS Group’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-22,218
| Closed | -$90K | – | 8949 |
|
|
2023
Q4 | $90K | Buy |
22,218
+11,468
| +107% | +$46.4K | ﹤0.01% | 5035 |
|
|
2023
Q3 | $28.9K | Buy |
10,750
+6,520
| +154% | +$17.5K | ﹤0.01% | 5473 |
|
|
2023
Q2 | $39.5K | Sell |
4,230
-2,621
| -38% | -$24.5K | ﹤0.01% | 5528 |
|
|
2023
Q1 | $60.8K | Buy |
6,851
+2,207
| +48% | +$19.6K | ﹤0.01% | 5222 |
|
|
2022
Q4 | $23.1K | Buy |
+4,644
| New | +$23.1K | ﹤0.01% | 6324 |
|
|
2022
Q2 | – | Sell |
-2,041
| Closed | -$24K | – | 10011 |
|
|
2022
Q1 | $24K | Sell |
2,041
-1,527
| -43% | -$18K | ﹤0.01% | 6223 |
|
|
2021
Q4 | $45K | Buy |
+3,568
| New | +$45K | ﹤0.01% | 5915 |
|